ExchangeDEX+
Buy CryptoMarketsSpotFuturesGOLDEarnEvent Center
More
ICP Zero-Fee Gala
PORTO, Portugal–(BUSINESS WIRE)–FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive OfficerPORTO, Portugal–(BUSINESS WIRE)–FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer

FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference

Author: AI JournalSource: AI Journal
2026/01/08 17:15
BIO Protocol
BIO$0.0325-4.35%
PoP Planet
P$0.01183-0.83%
FC Porto Fan Token
PORTO$1.0886+4.73%
Coupon Assets
CA$0.27269-4.81%
Moonveil
MORE$0.001008-24.66%

PORTO, Portugal–(BUSINESS WIRE)–FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 – 15, 2026 in San Francisco, CA.

With more than a decade of expertise, FJBio has supported over 250 clients across Pharma, Biotech and Academia and contributed to more than 19 antibodies advancing to clinical stage development or the market. During his presentation, Dr. Lanthaler will address FJBio’s strategic positioning as a highly efficient, integrated partner. He will showcase the Company’s antibody discovery and development solutions, with a focus on innovation, data-driven platforms and scalable collaboration models across the biopharmaceutical ecosystem.

Presenter

Role

Date

Time

Venue

Dr. Werner Lanthaler

CEO, FJBio

Jan 13

09:00–09:25 AM

“Golden Gate” at THE WESTIN, 32nd floor

In addition to the CEO presentation, members of FJBio’s Senior Management and Business Development teams will attend the conference for strategic discussions with representatives of global pharmaceutical companies, biotechnology innovators and other industry partners throughout the event.

Dr. Werner Lanthaler, Chief Executive Officer of FairJourney Bio, commented: “I look forward to presenting FairJourney Bio’s unique platform for partnered pipeline building at this year’s J.P. Morgan 2026 Healthcare Conference. This conference brings together a highly curated group of global healthcare leaders and innovators and I appreciate the opportunity to engage in meaningful dialogue around the future of efficient, data-enabled antibody discovery and development.”

Participation as a presenting company at this conference is highly selective and considered a significant distinction, reflecting FJBio’s growing global recognition and relevance within the international life sciences community. The conference provides an important platform for FJBio to strengthen existing relationships, explore new strategic partnerships and further position the Company as a trusted global partner across the full value chain.

Contacts

FairJourney Biologics
Hinnerk Rohwedder

Head of Marketing & Communications

hrohwedder@fjbio.com

Zyme Communications

Lily Jeffery
Email: lily.jeffery@zymecommunications.com
Tel: +44 (0)7891 477 378

Market Opportunity
BIO Protocol Logo
BIO Protocol Price(BIO)
$0.0325
$0.0325$0.0325
-4.80%
USD
BIO Protocol (BIO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

XRP Hits Record Transactions, But Price Struggles – What’s Next for the Crypto?

XRP Hits Record Transactions, But Price Struggles – What’s Next for the Crypto?

XRP Ledger hits record transactions but faces continued price struggle. Despite growth, XRP price declines as resistance levels hold strong. Record transaction
Share
Coinstats2026/02/01 21:02
Tom Lee: Crypto Market Under Short-Term Pressure, Long-Term Bull Market Still in Early Stages

Tom Lee: Crypto Market Under Short-Term Pressure, Long-Term Bull Market Still in Early Stages

PANews reported on February 1st that Tom Lee shared his 2026 market outlook during an appearance on the podcast "The Compound." Lee remains generally optimistic
Share
PANews2026/02/01 21:15
‘Alien Earth’ Composer Jeff Russo Dives Into Score For FX Series

‘Alien Earth’ Composer Jeff Russo Dives Into Score For FX Series

The post ‘Alien Earth’ Composer Jeff Russo Dives Into Score For FX Series appeared on BitcoinEthereumNews.com. FX’s Alien: Earth — Pictured: Timothy Olyphant as Kirsh. Courtesy of Patrick Brown/FX The following contains certain spoilers for Alien: Earth! When it came time to marry picture and music for FX’s Alien: Earth, series creator Noah Hawley did what he’s done for close to 20 years: call up Jeff Russo. “[He] said, ‘I’m adapting the Alien IP, for television. What do you think, musically?’” Russo recalls over Zoom. “We started talking and I began writing music for it. It seemed like…not a foregone conclusion, but a conversation that was being had.” A founder of Tonic and a previous member of Low Stars, the composer has scored all of Hawley’s film and television projects since The Unusuals (2009). “Everything I’ve learned about making music for storytelling, I learned by doing with him,” Russo adds. “He really knows what he wants. And when you have a confident filmmaker that is also open to artistic collaboration, it’s the best of all the worlds.” The first small screen translation of the nearly 50-year-old franchise known for straddling horror, sci-fi, and action genres, Alien: Earth takes place two years before the events of the 1979 original and nearly six decades before Aliens. “We talk a lot about trying to figure out what the underlying property is making our audience feel,” Russo explains. “Trying to create a unique narrative and way of telling the story, but at the same time, making the audience feel that same feeling. In this case, there’s that feeling of dread. There’s that tense, eerie feeling created with such a deft hand in Alien. And then [came Aliens, which was] such a great action piece. So how are we going to take those two ideas and sort of mix them together, have that be something unique and different, while eliciting the…
Share
BitcoinEthereumNews2025/09/18 07:23